AA
KITE

ALPS Advisors’s Kite Pharma, Inc. KITE Stock Holding History

ALPS Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-51,113
Closed -$5.3M – 916
2017
Q2 		$5.3M Buy
51,113
+3,940
+8% +$322K 0.04% 140
2017
Q1 		$3.7M Sell
47,173
-757
-2% -$46.8K 0.03% 152
2016
Q4 		$2.15M Sell
47,930
-15,297
-24% -$750K 0.02% 176
2016
Q3 		$3.53M Sell
63,227
-5,789
-8% -$323K 0.03% 159
2016
Q2 		$3.45M Buy
69,016
+14,867
+27% +$730K 0.03% 143
2016
Q1 		$2.49M Sell
54,149
-8,828
-14% -$428K 0.03% 144
2015
Q4 		$3.88M Buy
+62,977
New +$4.43M 0.04% 132

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ALPS Advisors's KITE Position: Q3 2017 in Review

ALPS Advisors sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 51,113 shares — an estimated $5.3M sold.

ALPS Advisors first reported a position in KITE in Q4 2015 and held it in 7 quarters. The position peaked at $5.3M in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • ALPS Advisors reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • ALPS Advisors sold 51,113 Kite Pharma, Inc. shares in Q3 2017, an estimated $5.3M.
  • ALPS Advisors first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 7 quarters.
  • ALPS Advisors's Kite Pharma, Inc. position peaked at $5.3M in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on ALPS Advisors's 13F filing for Q3 2017, filed 3 Nov 2017.